• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchLumos Pharma
    Picture of Lumos Pharma logo

    LUMO — Lumos Pharma News Story

    $4.330.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapMomentum Trap
    • Market Cap
      $37.41m
    • Enterprise Value
      $23.89m
    • Revenue
      $2.05m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • LUMO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    LUMO Dividends
    All News

    NASDAQ RESUMED AT 09:37 AM

    Picture of Lumos Pharma logoLumos Pharma
    01/07/2021 14:37
    NASDAQ RESUMED  LUMO.O  AT 09:37 AM
    

    Recent news on Lumos Pharma

    See all news
    • Lumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview

      01/11/2024 14:08
    • U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow

      23/10/2024 19:00
    • U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla

      23/10/2024 16:54
    • Lumos Pharma climbs on $38 mln go-private deal

      23/10/2024 16:24
    • Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)

      23/10/2024 14:01

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.